Optiver · 2 days ago
Quantitative Researcher - SVT
Optiver is growing its Systematic Volatility Trading team and is looking for an exceptional Quantitative Researcher to help define the direction of a fully automated options trading strategy. The role involves developing and refining alpha-driven strategies, researching novel signals, and optimizing trading performance.
Financial ServicesFinTechMarket Research
Responsibilities
Develop and refine alpha-driven strategies for fully automated options trading
Research and implement novel signals, models, and execution techniques to optimize trading performance
Play a key role in shaping the future of the team
Qualification
Required
4-5+ years of quantitative research experience, focused on alpha generation in equity or index options
BS, MS, and/or PhD in a quantitative or technical field
Strong individual contributor who thrives in a fast-paced, high-ownership environment
Strong programming and data analysis skills (Python, C++, or similar)
Ability to think differently, challenge assumptions, and identify unique trading opportunities
Excited to be an early-stage team member, helping to build and scale a world-class systematic vol trading effort
Benefits
Global profit-sharing pool and performance-based bonus structure
401(k) match up to 50%
Comprehensive health, mental, dental, vision, disability, and life coverage
25 paid vacation days alongside market holidays
Extensive office perks, including breakfast, lunch and snacks, regular social events, clubs, sporting leagues and more
Company
Optiver
Optiver is an international trading firm, headquartered in Amsterdam.
H1B Sponsorship
Optiver has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (28)
2024 (16)
2023 (36)
2022 (12)
2021 (13)
2020 (14)
Funding
Current Stage
Late StageRecent News
2026-01-22
2026-01-16
2025-11-25
Company data provided by crunchbase